nodes	percent_of_prediction	percent_of_DWPC	metapath
Loratadine—CYP2C8—Sorafenib—liver cancer	0.136	0.189	CbGbCtD
Loratadine—CYP2C19—Sorafenib—liver cancer	0.114	0.158	CbGbCtD
Loratadine—CYP2C9—Sorafenib—liver cancer	0.0947	0.132	CbGbCtD
Loratadine—ABCB1—Sorafenib—liver cancer	0.0919	0.128	CbGbCtD
Loratadine—CYP2D6—Sorafenib—liver cancer	0.0866	0.12	CbGbCtD
Loratadine—ABCB1—Doxorubicin—liver cancer	0.0558	0.0775	CbGbCtD
Loratadine—CYP3A4—Sorafenib—liver cancer	0.0551	0.0765	CbGbCtD
Loratadine—CYP2D6—Doxorubicin—liver cancer	0.0525	0.073	CbGbCtD
Loratadine—CYP3A4—Doxorubicin—liver cancer	0.0334	0.0464	CbGbCtD
Loratadine—Drug interaction—Sorafenib—liver cancer	0.00429	0.0319	CcSEcCtD
Loratadine—Abdominal pain upper—Sorafenib—liver cancer	0.00264	0.0196	CcSEcCtD
Loratadine—Gastritis—Sorafenib—liver cancer	0.00256	0.019	CcSEcCtD
Loratadine—Hepatobiliary disease—Sorafenib—liver cancer	0.00211	0.0157	CcSEcCtD
Loratadine—Epistaxis—Sorafenib—liver cancer	0.0021	0.0156	CcSEcCtD
Loratadine—Blister—Epirubicin—liver cancer	0.00204	0.0152	CcSEcCtD
Loratadine—Blister—Doxorubicin—liver cancer	0.00189	0.014	CcSEcCtD
Loratadine—Tinnitus—Sorafenib—liver cancer	0.00187	0.0139	CcSEcCtD
Loratadine—Immune system disorder—Sorafenib—liver cancer	0.00181	0.0134	CcSEcCtD
Loratadine—Arrhythmia—Sorafenib—liver cancer	0.00179	0.0133	CcSEcCtD
Loratadine—Alopecia—Sorafenib—liver cancer	0.00177	0.0131	CcSEcCtD
Loratadine—Dysgeusia—Sorafenib—liver cancer	0.00171	0.0127	CcSEcCtD
Loratadine—Cardiovascular disorder—Epirubicin—liver cancer	0.00168	0.0124	CcSEcCtD
Loratadine—Viral infection—Epirubicin—liver cancer	0.00163	0.0121	CcSEcCtD
Loratadine—Angioedema—Sorafenib—liver cancer	0.00159	0.0118	CcSEcCtD
Loratadine—Syncope—Sorafenib—liver cancer	0.00156	0.0116	CcSEcCtD
Loratadine—Cardiovascular disorder—Doxorubicin—liver cancer	0.00155	0.0115	CcSEcCtD
Loratadine—Loss of consciousness—Sorafenib—liver cancer	0.00153	0.0114	CcSEcCtD
Loratadine—Cough—Sorafenib—liver cancer	0.00152	0.0113	CcSEcCtD
Loratadine—Viral infection—Doxorubicin—liver cancer	0.00151	0.0112	CcSEcCtD
Loratadine—Hypertension—Sorafenib—liver cancer	0.0015	0.0112	CcSEcCtD
Loratadine—Myalgia—Sorafenib—liver cancer	0.00148	0.011	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00147	0.0109	CcSEcCtD
Loratadine—Dry mouth—Sorafenib—liver cancer	0.00145	0.0108	CcSEcCtD
Loratadine—Salivary hypersecretion—Epirubicin—liver cancer	0.00143	0.0106	CcSEcCtD
Loratadine—Anaphylactic shock—Sorafenib—liver cancer	0.00142	0.0106	CcSEcCtD
Loratadine—Shock—Sorafenib—liver cancer	0.0014	0.0104	CcSEcCtD
Loratadine—Nervous system disorder—Sorafenib—liver cancer	0.00139	0.0104	CcSEcCtD
Loratadine—Skin disorder—Sorafenib—liver cancer	0.00138	0.0103	CcSEcCtD
Loratadine—Salivary hypersecretion—Doxorubicin—liver cancer	0.00132	0.00982	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00129	0.00962	CcSEcCtD
Loratadine—Dyspepsia—Sorafenib—liver cancer	0.00125	0.00929	CcSEcCtD
Loratadine—Gastrointestinal disorder—Sorafenib—liver cancer	0.00123	0.00911	CcSEcCtD
Loratadine—Fatigue—Sorafenib—liver cancer	0.00123	0.0091	CcSEcCtD
Loratadine—Constipation—Sorafenib—liver cancer	0.00122	0.00903	CcSEcCtD
Loratadine—Pain—Sorafenib—liver cancer	0.00122	0.00903	CcSEcCtD
Loratadine—Gastrointestinal pain—Sorafenib—liver cancer	0.00116	0.00863	CcSEcCtD
Loratadine—Increased appetite—Epirubicin—liver cancer	0.00114	0.00845	CcSEcCtD
Loratadine—Abdominal pain—Sorafenib—liver cancer	0.00112	0.00834	CcSEcCtD
Loratadine—Body temperature increased—Sorafenib—liver cancer	0.00112	0.00834	CcSEcCtD
Loratadine—Dermatitis bullous—Epirubicin—liver cancer	0.00112	0.0083	CcSEcCtD
Loratadine—Lethargy—Epirubicin—liver cancer	0.00109	0.0081	CcSEcCtD
Loratadine—Increased appetite—Doxorubicin—liver cancer	0.00105	0.00782	CcSEcCtD
Loratadine—Dermatitis bullous—Doxorubicin—liver cancer	0.00103	0.00768	CcSEcCtD
Loratadine—Asthenia—Sorafenib—liver cancer	0.00102	0.00757	CcSEcCtD
Loratadine—Lethargy—Doxorubicin—liver cancer	0.00101	0.00749	CcSEcCtD
Loratadine—Abdominal pain upper—Epirubicin—liver cancer	0.000976	0.00725	CcSEcCtD
Loratadine—Diarrhoea—Sorafenib—liver cancer	0.000972	0.00722	CcSEcCtD
Loratadine—Gastritis—Epirubicin—liver cancer	0.000946	0.00702	CcSEcCtD
Loratadine—Dizziness—Sorafenib—liver cancer	0.00094	0.00698	CcSEcCtD
Loratadine—Vomiting—Sorafenib—liver cancer	0.000904	0.00671	CcSEcCtD
Loratadine—Abdominal pain upper—Doxorubicin—liver cancer	0.000903	0.00671	CcSEcCtD
Loratadine—Rash—Sorafenib—liver cancer	0.000896	0.00666	CcSEcCtD
Loratadine—Dermatitis—Sorafenib—liver cancer	0.000895	0.00665	CcSEcCtD
Loratadine—Headache—Sorafenib—liver cancer	0.00089	0.00661	CcSEcCtD
Loratadine—Gastritis—Doxorubicin—liver cancer	0.000875	0.0065	CcSEcCtD
Loratadine—Pollakiuria—Epirubicin—liver cancer	0.000853	0.00634	CcSEcCtD
Loratadine—Nausea—Sorafenib—liver cancer	0.000844	0.00627	CcSEcCtD
Loratadine—Drowsiness—Epirubicin—liver cancer	0.000824	0.00612	CcSEcCtD
Loratadine—Pollakiuria—Doxorubicin—liver cancer	0.000789	0.00586	CcSEcCtD
Loratadine—Hepatobiliary disease—Epirubicin—liver cancer	0.000779	0.00578	CcSEcCtD
Loratadine—Epistaxis—Epirubicin—liver cancer	0.000777	0.00577	CcSEcCtD
Loratadine—Drowsiness—Doxorubicin—liver cancer	0.000762	0.00566	CcSEcCtD
Loratadine—Pharyngitis—Epirubicin—liver cancer	0.000734	0.00545	CcSEcCtD
Loratadine—Hepatobiliary disease—Doxorubicin—liver cancer	0.000721	0.00535	CcSEcCtD
Loratadine—Epistaxis—Doxorubicin—liver cancer	0.000719	0.00534	CcSEcCtD
Loratadine—Tinnitus—Epirubicin—liver cancer	0.000689	0.00512	CcSEcCtD
Loratadine—Pharyngitis—Doxorubicin—liver cancer	0.000679	0.00504	CcSEcCtD
Loratadine—Immune system disorder—Epirubicin—liver cancer	0.000668	0.00496	CcSEcCtD
Loratadine—Arrhythmia—Epirubicin—liver cancer	0.00066	0.0049	CcSEcCtD
Loratadine—Alopecia—Epirubicin—liver cancer	0.000653	0.00485	CcSEcCtD
Loratadine—Tinnitus—Doxorubicin—liver cancer	0.000638	0.00474	CcSEcCtD
Loratadine—Tension—Epirubicin—liver cancer	0.000632	0.00469	CcSEcCtD
Loratadine—Dysgeusia—Epirubicin—liver cancer	0.00063	0.00468	CcSEcCtD
Loratadine—Nervousness—Epirubicin—liver cancer	0.000625	0.00464	CcSEcCtD
Loratadine—Immune system disorder—Doxorubicin—liver cancer	0.000618	0.00459	CcSEcCtD
Loratadine—Arrhythmia—Doxorubicin—liver cancer	0.000611	0.00454	CcSEcCtD
Loratadine—Alopecia—Doxorubicin—liver cancer	0.000604	0.00449	CcSEcCtD
Loratadine—Ill-defined disorder—Epirubicin—liver cancer	0.000597	0.00443	CcSEcCtD
Loratadine—Agitation—Epirubicin—liver cancer	0.000591	0.00439	CcSEcCtD
Loratadine—Tension—Doxorubicin—liver cancer	0.000584	0.00434	CcSEcCtD
Loratadine—Dysgeusia—Doxorubicin—liver cancer	0.000583	0.00433	CcSEcCtD
Loratadine—Malaise—Epirubicin—liver cancer	0.00058	0.00431	CcSEcCtD
Loratadine—Nervousness—Doxorubicin—liver cancer	0.000578	0.0043	CcSEcCtD
Loratadine—Syncope—Epirubicin—liver cancer	0.000577	0.00429	CcSEcCtD
Loratadine—Palpitations—Epirubicin—liver cancer	0.000569	0.00422	CcSEcCtD
Loratadine—Loss of consciousness—Epirubicin—liver cancer	0.000566	0.0042	CcSEcCtD
Loratadine—Cough—Epirubicin—liver cancer	0.000562	0.00417	CcSEcCtD
Loratadine—Hypertension—Epirubicin—liver cancer	0.000556	0.00413	CcSEcCtD
Loratadine—Ill-defined disorder—Doxorubicin—liver cancer	0.000553	0.0041	CcSEcCtD
Loratadine—Myalgia—Epirubicin—liver cancer	0.000548	0.00407	CcSEcCtD
Loratadine—Chest pain—Epirubicin—liver cancer	0.000548	0.00407	CcSEcCtD
Loratadine—Agitation—Doxorubicin—liver cancer	0.000547	0.00406	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000544	0.00404	CcSEcCtD
Loratadine—Discomfort—Epirubicin—liver cancer	0.000541	0.00402	CcSEcCtD
Loratadine—Malaise—Doxorubicin—liver cancer	0.000537	0.00399	CcSEcCtD
Loratadine—Dry mouth—Epirubicin—liver cancer	0.000536	0.00398	CcSEcCtD
Loratadine—Syncope—Doxorubicin—liver cancer	0.000534	0.00397	CcSEcCtD
Loratadine—Palpitations—Doxorubicin—liver cancer	0.000526	0.00391	CcSEcCtD
Loratadine—Anaphylactic shock—Epirubicin—liver cancer	0.000525	0.0039	CcSEcCtD
Loratadine—Loss of consciousness—Doxorubicin—liver cancer	0.000523	0.00389	CcSEcCtD
Loratadine—Cough—Doxorubicin—liver cancer	0.00052	0.00386	CcSEcCtD
Loratadine—Shock—Epirubicin—liver cancer	0.000517	0.00384	CcSEcCtD
Loratadine—Nervous system disorder—Epirubicin—liver cancer	0.000515	0.00383	CcSEcCtD
Loratadine—Hypertension—Doxorubicin—liver cancer	0.000514	0.00382	CcSEcCtD
Loratadine—Tachycardia—Epirubicin—liver cancer	0.000513	0.00381	CcSEcCtD
Loratadine—Skin disorder—Epirubicin—liver cancer	0.00051	0.00379	CcSEcCtD
Loratadine—Chest pain—Doxorubicin—liver cancer	0.000507	0.00377	CcSEcCtD
Loratadine—Myalgia—Doxorubicin—liver cancer	0.000507	0.00377	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000503	0.00374	CcSEcCtD
Loratadine—Discomfort—Doxorubicin—liver cancer	0.000501	0.00372	CcSEcCtD
Loratadine—Dry mouth—Doxorubicin—liver cancer	0.000496	0.00368	CcSEcCtD
Loratadine—Hypotension—Epirubicin—liver cancer	0.000491	0.00365	CcSEcCtD
Loratadine—Anaphylactic shock—Doxorubicin—liver cancer	0.000486	0.00361	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000479	0.00355	CcSEcCtD
Loratadine—Shock—Doxorubicin—liver cancer	0.000478	0.00355	CcSEcCtD
Loratadine—Nervous system disorder—Doxorubicin—liver cancer	0.000477	0.00354	CcSEcCtD
Loratadine—Insomnia—Epirubicin—liver cancer	0.000475	0.00353	CcSEcCtD
Loratadine—Tachycardia—Doxorubicin—liver cancer	0.000474	0.00352	CcSEcCtD
Loratadine—Skin disorder—Doxorubicin—liver cancer	0.000472	0.00351	CcSEcCtD
Loratadine—Paraesthesia—Epirubicin—liver cancer	0.000472	0.0035	CcSEcCtD
Loratadine—Somnolence—Epirubicin—liver cancer	0.000467	0.00347	CcSEcCtD
Loratadine—Dyspepsia—Epirubicin—liver cancer	0.000462	0.00343	CcSEcCtD
Loratadine—Hypotension—Doxorubicin—liver cancer	0.000454	0.00337	CcSEcCtD
Loratadine—Gastrointestinal disorder—Epirubicin—liver cancer	0.000453	0.00337	CcSEcCtD
Loratadine—Fatigue—Epirubicin—liver cancer	0.000453	0.00336	CcSEcCtD
Loratadine—Pain—Epirubicin—liver cancer	0.000449	0.00334	CcSEcCtD
Loratadine—Constipation—Epirubicin—liver cancer	0.000449	0.00334	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000443	0.00329	CcSEcCtD
Loratadine—Insomnia—Doxorubicin—liver cancer	0.00044	0.00326	CcSEcCtD
Loratadine—Paraesthesia—Doxorubicin—liver cancer	0.000436	0.00324	CcSEcCtD
Loratadine—Feeling abnormal—Epirubicin—liver cancer	0.000433	0.00321	CcSEcCtD
Loratadine—Somnolence—Doxorubicin—liver cancer	0.000432	0.00321	CcSEcCtD
Loratadine—Gastrointestinal pain—Epirubicin—liver cancer	0.00043	0.00319	CcSEcCtD
Loratadine—Dyspepsia—Doxorubicin—liver cancer	0.000428	0.00318	CcSEcCtD
Loratadine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00042	0.00312	CcSEcCtD
Loratadine—Fatigue—Doxorubicin—liver cancer	0.000419	0.00311	CcSEcCtD
Loratadine—Pain—Doxorubicin—liver cancer	0.000416	0.00309	CcSEcCtD
Loratadine—Constipation—Doxorubicin—liver cancer	0.000416	0.00309	CcSEcCtD
Loratadine—Abdominal pain—Epirubicin—liver cancer	0.000415	0.00308	CcSEcCtD
Loratadine—Body temperature increased—Epirubicin—liver cancer	0.000415	0.00308	CcSEcCtD
Loratadine—Feeling abnormal—Doxorubicin—liver cancer	0.0004	0.00297	CcSEcCtD
Loratadine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000397	0.00295	CcSEcCtD
Loratadine—Body temperature increased—Doxorubicin—liver cancer	0.000384	0.00285	CcSEcCtD
Loratadine—Abdominal pain—Doxorubicin—liver cancer	0.000384	0.00285	CcSEcCtD
Loratadine—Asthenia—Epirubicin—liver cancer	0.000377	0.0028	CcSEcCtD
Loratadine—Diarrhoea—Epirubicin—liver cancer	0.000359	0.00267	CcSEcCtD
Loratadine—Asthenia—Doxorubicin—liver cancer	0.000349	0.00259	CcSEcCtD
Loratadine—Dizziness—Epirubicin—liver cancer	0.000347	0.00258	CcSEcCtD
Loratadine—Vomiting—Epirubicin—liver cancer	0.000334	0.00248	CcSEcCtD
Loratadine—Diarrhoea—Doxorubicin—liver cancer	0.000333	0.00247	CcSEcCtD
Loratadine—Rash—Epirubicin—liver cancer	0.000331	0.00246	CcSEcCtD
Loratadine—Dermatitis—Epirubicin—liver cancer	0.000331	0.00246	CcSEcCtD
Loratadine—Headache—Epirubicin—liver cancer	0.000329	0.00244	CcSEcCtD
Loratadine—Dizziness—Doxorubicin—liver cancer	0.000321	0.00239	CcSEcCtD
Loratadine—Nausea—Epirubicin—liver cancer	0.000312	0.00232	CcSEcCtD
Loratadine—Vomiting—Doxorubicin—liver cancer	0.000309	0.00229	CcSEcCtD
Loratadine—Rash—Doxorubicin—liver cancer	0.000306	0.00228	CcSEcCtD
Loratadine—Dermatitis—Doxorubicin—liver cancer	0.000306	0.00227	CcSEcCtD
Loratadine—Headache—Doxorubicin—liver cancer	0.000304	0.00226	CcSEcCtD
Loratadine—Nausea—Doxorubicin—liver cancer	0.000289	0.00214	CcSEcCtD
Loratadine—HRH1—Signaling by GPCR—CSF2—liver cancer	4.92e-05	0.000338	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	4.87e-05	0.000334	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	4.86e-05	0.000333	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	4.84e-05	0.000332	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GSTA4—liver cancer	4.83e-05	0.000331	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GSTA2—liver cancer	4.82e-05	0.000331	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CRABP1—liver cancer	4.71e-05	0.000323	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GSTA2—liver cancer	4.71e-05	0.000323	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GSTA1—liver cancer	4.65e-05	0.000319	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—NAT2—liver cancer	4.6e-05	0.000316	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GSTA4—liver cancer	4.55e-05	0.000312	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GSTA1—liver cancer	4.54e-05	0.000311	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	4.54e-05	0.000311	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ADAM17—liver cancer	4.51e-05	0.00031	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GSTA4—liver cancer	4.51e-05	0.000309	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	4.5e-05	0.000309	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—NAT2—liver cancer	4.49e-05	0.000308	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GSTA2—liver cancer	4.44e-05	0.000304	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	4.42e-05	0.000303	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ALDOB—liver cancer	4.41e-05	0.000303	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	4.41e-05	0.000302	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GSTA2—liver cancer	4.4e-05	0.000302	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ALDOB—liver cancer	4.31e-05	0.000295	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GSTA1—liver cancer	4.28e-05	0.000294	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—F2—liver cancer	4.25e-05	0.000292	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	4.24e-05	0.000291	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PSMA4—liver cancer	4.24e-05	0.000291	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PSMD10—liver cancer	4.24e-05	0.000291	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GSTA1—liver cancer	4.24e-05	0.000291	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—NAT2—liver cancer	4.23e-05	0.00029	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CRABP1—liver cancer	4.21e-05	0.000289	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—NAT2—liver cancer	4.19e-05	0.000288	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	4.14e-05	0.000284	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—HPGDS—liver cancer	4.12e-05	0.000283	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CRABP1—liver cancer	4.11e-05	0.000282	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	4.11e-05	0.000282	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	4.1e-05	0.000281	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—PIK3CG—liver cancer	4.07e-05	0.000279	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ALDOB—liver cancer	4.06e-05	0.000278	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	4.03e-05	0.000277	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ALDOB—liver cancer	4.02e-05	0.000276	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	4e-05	0.000274	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CRABP1—liver cancer	3.87e-05	0.000265	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—F2—liver cancer	3.86e-05	0.000265	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CRABP1—liver cancer	3.84e-05	0.000263	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.79e-05	0.00026	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.73e-05	0.000256	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—PIK3CG—liver cancer	3.7e-05	0.000254	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.68e-05	0.000253	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—HPGDS—liver cancer	3.68e-05	0.000252	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PSMA4—liver cancer	3.67e-05	0.000252	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PSMD10—liver cancer	3.67e-05	0.000252	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.66e-05	0.000251	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—HPGDS—liver cancer	3.59e-05	0.000246	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—PIK3CD—liver cancer	3.58e-05	0.000245	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GOT2—liver cancer	3.57e-05	0.000245	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.45e-05	0.000237	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GLUL—liver cancer	3.43e-05	0.000235	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CPT1B—liver cancer	3.43e-05	0.000235	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—HPGDS—liver cancer	3.38e-05	0.000232	CbGpPWpGaD
Loratadine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	3.38e-05	0.000232	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CYP2E1—liver cancer	3.36e-05	0.00023	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—HPGDS—liver cancer	3.35e-05	0.00023	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.33e-05	0.000229	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.33e-05	0.000228	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NR1H4—liver cancer	3.31e-05	0.000227	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.29e-05	0.000226	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PRKCE—liver cancer	3.29e-05	0.000225	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PSMA4—liver cancer	3.28e-05	0.000225	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PSMD10—liver cancer	3.28e-05	0.000225	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTA3—liver cancer	3.25e-05	0.000223	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.25e-05	0.000223	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—PIK3CD—liver cancer	3.25e-05	0.000223	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PSMA4—liver cancer	3.2e-05	0.000219	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PSMD10—liver cancer	3.2e-05	0.000219	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GOT2—liver cancer	3.19e-05	0.000219	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CYCS—liver cancer	3.14e-05	0.000216	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—PIK3CB—liver cancer	3.12e-05	0.000214	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IGF2—liver cancer	3.11e-05	0.000214	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GOT2—liver cancer	3.11e-05	0.000213	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GGT1—liver cancer	3.08e-05	0.000212	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GOT1—liver cancer	3.08e-05	0.000212	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	3.05e-05	0.000209	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.04e-05	0.000208	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PSMD10—liver cancer	3.02e-05	0.000207	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PSMA4—liver cancer	3.02e-05	0.000207	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYP2E1—liver cancer	3e-05	0.000206	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	3e-05	0.000206	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PSMA4—liver cancer	2.99e-05	0.000205	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PSMD10—liver cancer	2.99e-05	0.000205	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTA4—liver cancer	2.98e-05	0.000204	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GOT2—liver cancer	2.93e-05	0.000201	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYP2E1—liver cancer	2.93e-05	0.000201	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CSF2—liver cancer	2.91e-05	0.000199	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GOT2—liver cancer	2.91e-05	0.000199	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.9e-05	0.000199	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—RAF1—liver cancer	2.9e-05	0.000199	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTA2—liver cancer	2.9e-05	0.000199	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—H2AFX—liver cancer	2.87e-05	0.000197	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—IL2—liver cancer	2.87e-05	0.000197	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—PIK3CB—liver cancer	2.83e-05	0.000194	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYCS—liver cancer	2.81e-05	0.000192	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTA1—liver cancer	2.8e-05	0.000192	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GSTP1—liver cancer	2.77e-05	0.00019	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—NAT2—liver cancer	2.77e-05	0.00019	CbGpPWpGaD
Loratadine—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	2.76e-05	0.000189	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP2E1—liver cancer	2.76e-05	0.000189	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GGT1—liver cancer	2.75e-05	0.000189	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GOT1—liver cancer	2.75e-05	0.000189	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYCS—liver cancer	2.74e-05	0.000188	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP2E1—liver cancer	2.73e-05	0.000188	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—HMOX1—liver cancer	2.73e-05	0.000187	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GOT1—liver cancer	2.69e-05	0.000184	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GGT1—liver cancer	2.69e-05	0.000184	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ALDOB—liver cancer	2.65e-05	0.000182	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.65e-05	0.000182	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—IL2—liver cancer	2.6e-05	0.000178	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TERT—liver cancer	2.59e-05	0.000178	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYCS—liver cancer	2.58e-05	0.000177	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYCS—liver cancer	2.56e-05	0.000175	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—GSTM1—liver cancer	2.55e-05	0.000175	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GGT1—liver cancer	2.53e-05	0.000174	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GOT1—liver cancer	2.53e-05	0.000174	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CRABP1—liver cancer	2.53e-05	0.000174	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GGT1—liver cancer	2.51e-05	0.000172	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GOT1—liver cancer	2.51e-05	0.000172	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GSTP1—liver cancer	2.47e-05	0.00017	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—HMOX1—liver cancer	2.44e-05	0.000167	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GSTP1—liver cancer	2.41e-05	0.000166	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—CYP1A1—liver cancer	2.41e-05	0.000166	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—HMOX1—liver cancer	2.38e-05	0.000163	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—KDR—liver cancer	2.37e-05	0.000163	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MAPK14—liver cancer	2.36e-05	0.000162	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—ESR1—liver cancer	2.31e-05	0.000158	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—F2—liver cancer	2.28e-05	0.000157	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GSTP1—liver cancer	2.27e-05	0.000156	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—GSTM1—liver cancer	2.27e-05	0.000156	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GSTP1—liver cancer	2.25e-05	0.000155	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—MTHFR—liver cancer	2.25e-05	0.000154	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—HMOX1—liver cancer	2.24e-05	0.000154	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—HMOX1—liver cancer	2.22e-05	0.000153	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—GSTM1—liver cancer	2.22e-05	0.000152	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—HPGDS—liver cancer	2.21e-05	0.000152	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PPARA—liver cancer	2.21e-05	0.000151	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CG—liver cancer	2.18e-05	0.00015	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—APC—liver cancer	2.18e-05	0.00015	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—CYP1A1—liver cancer	2.15e-05	0.000148	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—CYP1A1—liver cancer	2.1e-05	0.000144	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—GSTM1—liver cancer	2.09e-05	0.000143	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—GSTM1—liver cancer	2.07e-05	0.000142	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—BRAF—liver cancer	2.05e-05	0.000141	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—MTHFR—liver cancer	2.01e-05	0.000138	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.98e-05	0.000136	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—CYP1A1—liver cancer	1.98e-05	0.000136	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PSMD10—liver cancer	1.97e-05	0.000135	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PSMA4—liver cancer	1.97e-05	0.000135	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PPARA—liver cancer	1.97e-05	0.000135	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—CYP1A1—liver cancer	1.96e-05	0.000135	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—MTHFR—liver cancer	1.96e-05	0.000134	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PPARA—liver cancer	1.92e-05	0.000132	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CD—liver cancer	1.92e-05	0.000132	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GOT2—liver cancer	1.92e-05	0.000132	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—PIK3CA—liver cancer	1.9e-05	0.00013	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—SERPINE1—liver cancer	1.9e-05	0.00013	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CG—liver cancer	1.89e-05	0.00013	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—KRAS—liver cancer	1.88e-05	0.000129	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—MTHFR—liver cancer	1.85e-05	0.000127	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—MTHFR—liver cancer	1.83e-05	0.000126	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PPARG—liver cancer	1.82e-05	0.000125	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PPARA—liver cancer	1.81e-05	0.000124	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP2E1—liver cancer	1.8e-05	0.000124	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PPARA—liver cancer	1.8e-05	0.000123	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.77e-05	0.000121	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—PIK3CA—liver cancer	1.73e-05	0.000118	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—RAF1—liver cancer	1.71e-05	0.000118	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CG—liver cancer	1.69e-05	0.000116	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYCS—liver cancer	1.69e-05	0.000116	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MTOR—liver cancer	1.67e-05	0.000115	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CB—liver cancer	1.67e-05	0.000115	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CD—liver cancer	1.66e-05	0.000114	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GOT1—liver cancer	1.66e-05	0.000114	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GGT1—liver cancer	1.66e-05	0.000114	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CG—liver cancer	1.65e-05	0.000113	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—ALB—liver cancer	1.64e-05	0.000113	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PPARG—liver cancer	1.63e-05	0.000112	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.61e-05	0.000111	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—HRAS—liver cancer	1.6e-05	0.00011	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PPARG—liver cancer	1.59e-05	0.000109	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CDKN1B—liver cancer	1.57e-05	0.000108	CbGpPWpGaD
Loratadine—HRH1—GPCR downstream signaling—AKT1—liver cancer	1.55e-05	0.000107	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CG—liver cancer	1.55e-05	0.000106	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CASP3—liver cancer	1.54e-05	0.000106	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CG—liver cancer	1.54e-05	0.000106	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IL2—liver cancer	1.54e-05	0.000105	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—IL6—liver cancer	1.53e-05	0.000105	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CCND1—liver cancer	1.5e-05	0.000103	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PPARG—liver cancer	1.5e-05	0.000103	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—JUN—liver cancer	1.5e-05	0.000103	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTP1—liver cancer	1.49e-05	0.000102	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PPARG—liver cancer	1.48e-05	0.000102	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CTNNB1—liver cancer	1.48e-05	0.000102	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CD—liver cancer	1.48e-05	0.000102	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—HMOX1—liver cancer	1.47e-05	0.000101	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—ALB—liver cancer	1.46e-05	0.0001	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MMP9—liver cancer	1.45e-05	9.98e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—CDKN1A—liver cancer	1.45e-05	9.94e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CB—liver cancer	1.45e-05	9.93e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CD—liver cancer	1.45e-05	9.93e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—ALB—liver cancer	1.43e-05	9.8e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MAPK8—liver cancer	1.41e-05	9.7e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling by GPCR—AKT1—liver cancer	1.41e-05	9.68e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—GSTM1—liver cancer	1.37e-05	9.37e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CD—liver cancer	1.36e-05	9.36e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CD—liver cancer	1.35e-05	9.28e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—ALB—liver cancer	1.35e-05	9.24e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—ALB—liver cancer	1.34e-05	9.16e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—VEGFA—liver cancer	1.31e-05	8.96e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—CYP1A1—liver cancer	1.3e-05	8.88e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—STAT3—liver cancer	1.29e-05	8.87e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CB—liver cancer	1.29e-05	8.87e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CB—liver cancer	1.26e-05	8.65e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—MTHFR—liver cancer	1.21e-05	8.28e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—MYC—liver cancer	1.2e-05	8.24e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TGFB1—liver cancer	1.2e-05	8.22e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CB—liver cancer	1.19e-05	8.16e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PPARA—liver cancer	1.18e-05	8.13e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CB—liver cancer	1.18e-05	8.09e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—KRAS—liver cancer	1.11e-05	7.62e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—PIK3CA—liver cancer	1.02e-05	7e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CG—liver cancer	1.01e-05	6.96e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—TP53—liver cancer	9.87e-06	6.77e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PPARG—liver cancer	9.79e-06	6.72e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—HRAS—liver cancer	9.44e-06	6.47e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—IL6—liver cancer	9.03e-06	6.2e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CD—liver cancer	8.92e-06	6.12e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—PIK3CA—liver cancer	8.83e-06	6.06e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—ALB—liver cancer	8.81e-06	6.04e-05	CbGpPWpGaD
Loratadine—HRH1—Signaling Pathways—AKT1—liver cancer	8.33e-06	5.72e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—PIK3CA—liver cancer	7.88e-06	5.41e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CB—liver cancer	7.77e-06	5.33e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—PIK3CA—liver cancer	7.69e-06	5.28e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—PIK3CA—liver cancer	7.25e-06	4.97e-05	CbGpPWpGaD
Loratadine—CYP2C8—Metabolism—AKT1—liver cancer	7.21e-06	4.95e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—PIK3CA—liver cancer	7.19e-06	4.93e-05	CbGpPWpGaD
Loratadine—CYP2C19—Metabolism—AKT1—liver cancer	6.44e-06	4.42e-05	CbGpPWpGaD
Loratadine—ABCB1—Metabolism—AKT1—liver cancer	6.28e-06	4.31e-05	CbGpPWpGaD
Loratadine—CYP2D6—Metabolism—AKT1—liver cancer	5.92e-06	4.06e-05	CbGpPWpGaD
Loratadine—CYP2C9—Metabolism—AKT1—liver cancer	5.87e-06	4.03e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—PIK3CA—liver cancer	4.74e-06	3.25e-05	CbGpPWpGaD
Loratadine—CYP3A4—Metabolism—AKT1—liver cancer	3.87e-06	2.66e-05	CbGpPWpGaD
